Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-09-20 Capital/Financing Update
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Zawarcie umowy dotacji z Narodowym Centrum Badań i Rozwoju / Conclusion of the grant agreement with the National Center for Research and Development - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is an official announcement by the Management Board of Selvita S.A. detailing the conclusion of a grant agreement with the National Center for Research and Development (NCBR) for a specific project related to drug development. It outlines the project's value, funding amount, timeline, and scientific scope. This type of announcement, concerning significant funding, grants, or material contracts that impact the company's operations or financial structure, typically falls under Capital/Financing Update (CAP) or sometimes Regulatory Filings (RNS) if it's a mandatory disclosure not covered elsewhere. Since it explicitly details the securing of funding/financing for a project, 'CAP' is the most appropriate specific category. It is not an earnings release, an annual report, or a management discussion, but a specific corporate action regarding financing.
2021-09-20 Polish
Zawarcie umowy dotacji z Narodowym Centrum Badań i Rozwoju / Conclusion of the grant agreement with the National Center for Research and Development - Content (PL)
Regulatory Filings Classification · 100% confidence The document is an official announcement from the Management Board of Selvita S.A. regarding the conclusion of a grant agreement with the National Center for Research and Development (NCBiR) for a specific project. It details the project's purpose, value, and funding amount. This type of announcement, concerning financing, grants, or capital structure changes, aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific financing event.
2021-09-06 Polish
Powiadomienie SLV_art. 19 MAR_Dawid Radziszewski
Director's Dealing Classification · 100% confidence The document is a standardized notification form, explicitly titled 'Standard form – Notification of transaction/(s)* referred to in Article 19(1) of the MAR for a person discharging managerial responsibilities'. Article 19 of the Market Abuse Regulation (MAR) mandates that persons discharging managerial responsibilities (PDMRs) must notify the issuer and the competent authority of transactions conducted on their own account relating to the shares or debt instruments of that issuer. This specific filing details a 'Purchase' transaction by a 'Członek Zarządu' (Board Member) of 'Selvita S.A.'. This directly corresponds to the definition of Director's Dealing (insider trades by executives).
2021-08-13 Polish
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego / Notification from person discharging managerial responsibilities in the Company due to...
Remuneration Information Classification · 99% confidence The document is a short notification from the Management Board of Selvita S.A. informing the public that they received a notification regarding a transaction by a Management Board Member (Mr. Dawid Radziszewski) related to a Stock Grant Program, referencing MAR Article 19.1. This type of transaction report by an executive/director concerning their personal holdings is specifically classified as Director's Dealing (DIRS). Although the actual notification content is attached, the primary document itself is the announcement of receiving that insider transaction report.
2021-08-13 Polish
Powiadomienie_art. 19 MAR_Paweł Przewięźlikowski_SLV
Director's Dealing Classification · 100% confidence The document is a standardized notification form, explicitly titled 'Standard form – Notification of transaction/(s)* referred to in Article 19(1) of the MAR for a person discharging managerial responsibilities'. This type of filing reports personal share transactions by directors or senior management (insider trades). This directly corresponds to the definition for Director's Dealing (DIRS). The content details the name of the person (Paweł Przewięźlikowski), their position (Supervisory Board Member), the issuer (Selvita S.A.), the transaction type (Issue of Shares as part of the Stock Grant Program - donation), price, volume, and date. This is a classic DIRS filing, not a general regulatory announcement (RNS) or a report itself.
2021-08-13 Polish
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego / Notification from person discharging managerial responsibilities in the Company due to ...
Share Issue/Capital Change Classification · 99% confidence The document text is very short (1048 characters) and explicitly states that the detailed notification (which concerns a transaction by a Supervisory Board Member, Mr. Paweł Przewięźlikowski, related to a Stock Grant Program, referencing MAR Article 19.1) is 'attached to this report' ('Treść powiadomienia stanowi załącznik do niniejszego raportu' / 'The notification is attached to this report'). This structure—a brief announcement stating that the substantive information is attached—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content specifically relates to insider transactions by a director/executive (Director's Dealing), the most precise classification is DIRS. However, the document itself is merely announcing the attached notification, not containing the full details of the transaction. Given the 'MENU VS MEAL' rule, if the core information is attached, it leans towards RPA or RNS. Since DIRS is a specific category for director transactions, and this document is the official notification of that transaction being received, it is highly related to DIRS. But because the text itself is just the cover letter stating the actual notification is attached, it is best classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the context of MAR Article 19 notifications, these are often treated as specific regulatory disclosures. Since DIRS is for the report of the transaction itself, and this is the announcement of receiving that report, RPA is a strong candidate. However, looking at the definitions, DIRS (Director's Dealing) is the subject matter. If the attached document is the DIRS form, this announcement is the RPA. If we must choose the most specific category based on the subject matter being announced, DIRS is relevant, but based on the structure (announcing an attachment), RPA is more accurate for this wrapper document. Let's re-evaluate: Director's Dealing (DIRS) is the specific event. This document is the official announcement of receiving the MAR 19 notification, which is a regulatory requirement concerning insider trading. Since the actual transaction details are in the attachment, this wrapper document is best classified as a general Regulatory Filing (RNS) or RPA. Given the specific nature of MAR 19, RNS is often used for general regulatory disclosures not covered elsewhere. Since the content is about a director's transaction, DIRS is the subject. I will classify it as DIRS because the core purpose is to disclose the director's dealing, even if the details are attached, as this is the official disclosure mechanism for that event.
2021-08-13 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.